Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients

scientific article published in March 2012

Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1041757245
P356DOI10.1007/S12094-012-0786-2
P698PubMed publication ID22374425

P2093author name stringGang Li
Ruxiang Xu
Jianping Deng
Shiming He
Hongliu Lu
Jianfang Fu
Yanyang Tu
P2860cites workEphB4 expression and biological significance in prostate cancerQ24304334
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaQ24647476
Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinomaQ28137761
Mechanisms and functions of Eph and ephrin signallingQ28208291
The Eph family of receptorsQ28251298
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinomaQ31105340
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisQ33677805
Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growthQ33745300
Recurrent high-grade glioma: a diagnostic and therapeutic challengeQ33864058
Clinical development of experimental therapies for malignant glioma.Q34782295
Receptor tyrosine kinase EphB4 is a survival factor in breast cancerQ35221906
Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitmentQ36962774
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growthQ37334601
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growthQ37682093
EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.Q39636239
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progressionQ39861032
Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockadeQ39883638
The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinomaQ40046746
EphB4 provides survival advantage to squamous cell carcinoma of the head and neckQ40292503
EphB4 controls blood vascular morphogenesis during postnatal angiogenesisQ40327178
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.Q40365399
EphB receptor activity suppresses colorectal cancer progressionQ40405920
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic applicationQ40554993
EphrinB2 and EphB4 expression in pterygia: new insights and preliminary resultsQ42454748
Tumor vessels are Eph-ing complicatedQ43563869
Expression of Ephb2 and Ephb4 in breast carcinomaQ44804369
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancersQ48030369
Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.Q51776814
Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.Q54571370
Patients' and staff's experiences of multidisciplinary follow-up for high-grade glioma after radical radiotherapy.Q55463219
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodiesQ69898972
World Health Organization classification of tumorsQ73931466
Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculatureQ79074131
P433issue3
P921main subjectglioblastomaQ282142
P304page(s)214-220
P577publication date2012-03-01
P1433published inClinical and Translational OncologyQ15754324
P1476titleExpression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients
P478volume14

Reverse relations

cites work (P2860)
Q89514362Angiocrine endothelium: from physiology to cancer
Q53403455Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
Q55286883Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
Q27000196Eph receptors as therapeutic targets in glioblastoma
Q47146373Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency.
Q38878649EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System
Q41520269EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation
Q55456644EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
Q42529862EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
Q37153834EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
Q27015780Ephs and Ephrins in malignant gliomas
Q37557031Expression of Potential Regulatory Genes in Abdominal Adipose Tissue of Broiler Chickens during Early Development
Q64986508High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer.
Q38765961KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors
Q37312725Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival
Q98771280PDCD10-Deficiency Promotes Malignant Behaviors and Tumor Growth via Triggering EphB4 Kinase Activity in Glioblastoma
Q58117045Receptor-Targeted Glial Brain Tumor Therapies
Q64097285The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
Q47108317The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
Q37723106The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

Search more.